In the ongoing battle against contagious diseases, researchers at the Innovation Center of NanoMedicine's Uchida Laboratory have made a significant breakthrough with the creation of a "naked mRNA" vaccine. This innovative technology harnesses messenger RNA to invoke an immune response without the
Lantern Pharma's LP-300 signals a significant advancement in the fight against non-small cell lung cancer (NSCLC), particularly in never-smokers—a group seeing elevated incidence rates, notably in East Asia. This promising therapeutic option stands out as NSCLC treatments often overlook the unique
In the fight against kidney cancer, ALLO-316, created by Allogene Therapeutics, stands out in the vanguard with its CAR T-cell therapy. This breakthrough offers new hope against renal cell carcinoma (RCC), a type notorious for its defiance against traditional treatments. As ALLO-316 progresses
Algorae Pharmaceuticals is revolutionizing the field of medicine with its state-of-the-art AI system, AlgoraeOS. By leveraging the extraordinary capabilities of Gadi, the mightiest supercomputer in the Southern Hemisphere, Algorae leads innovation in reimagining the use of existing medications.
A Breakthrough in Vaccine Delivery In a revolutionary shift from conventional immunization methods, scientists at Tokyo Medical and Dental University's Uchida Laboratory, along with various prestigious institutions, have created a "naked" mRNA vaccine for SARS-CoV-2. This cutting-edge vaccine does
In a decisive move to safeguard financial stability and bolster public trust, the United States government has announced a significant intervention in the wake of the Silicon Valley Bank (SVB) failure. Unprecedented Access to Depositor Funds Starting on Monday, former clients of SVB are assured
